Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Value-Added Schizophrenia Round-Up: Luye Expects Chinese First With US Risperidone
Several companies are making progress on developing and launching added-value schizophrenia treatments • Source: Shutterstock
More from Value Added Medicines
More from Products